Genmab — Juli 2019
-
Iberdomide
Iberdomide | C25H27N3O5 | CID 67335295 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.
(pubchem.ncbi.nlm.nih.gov)
-
Dara on the PRAC agenda again, Extension of indication to extend the existing therapeutic indication for Darzalex
(daratumumab) in combination with 1) lenalidomide and dexamethasone 2) bortezomib, thalidomide and dexamethasone https://www.ema.europa.eu/en/documents/agenda/agenda-prac-draft-agenda-meeting-8-11-july-2019_en.pdf -
Iflg. wikiopslaget https://en.wikipedia.org/wiki/Immunomodulatory_imide_drug , kap.1, Generations er: Thalidomide 1. gen, Lenalidomide OG Pomalidomide 2. gen samt Apremilast 3. gen. Iberdomide har mærkværdigvis intet wikiopslag.. kunne ikke umiddelbart finde en dannende (pixi)artikel - har du evt. ref. til en, Sukker?
-
Er det mon kun Simon, blandt danske analytikere, der er på arbejde? https://penge.borsen.dk/artikel/1/384295/genmab-aktien_til_vejrs_i_surt_marked_efter_positive_studieresultater.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind